SLA2 and acute myeloid leukemia: We observed an increase in expression of SLAP2 in AML patients carrying FLT3-ITD mutations and FLT3-ITD positive AML patients having comparatively lower SLAP2 expression suffer from intermediate or poor prognosis suggesting that SLAP2 plays an important role in FLT3-ITD driven AML.